MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuroprotective effects of allicin microemulsion against intrastriatal rotenone and manganese induced Parkinsonism in rats

S. Singh (Moga, India)

Meeting: MDS Virtual Congress 2020

Abstract Number: 297

Keywords: Drug-induced parkinsonism(DIP), Glutamate, Rotenone

Category: Neuropharmacology

Objective: Allicin is flavonoid that possess neuroprotective potential but main impediment is its low bioavailability which was improved with microemulsion. The present study was framed to find the neuroprotective effect of allicin microemulsion against rotenone and manganese induced Parkinsonism in rats.

Background: Rotenone is a neurotoxin that inhibits mitochondrial ETC complex-I and causes dopaminergic neurodegeneration, deficiency of dopamine in brain accompanied by Parkinsonism both in human and rodents. Manganese is a trace element required for the normal growth and development in human and animals but at higher concentration it causes CNS dysfunction known as manganism also synergies the toxic effect of rotenone.

Method: Rats were administered with rotenone (6µg/µl/kg) once unilaterally and manganese (30mg/kg; p.o.) were given for 28 days. Behavioral (open field, rotarod, narrow beam walk, grip strength) analysis was performed weekly on 1st 7th 14th 21st and 28th day. After rotenone and manganese, on 7th day animals were administered with allicin microemulsion (10 and 30 mg/kg; i.p.) for 21 days. Rats were sacrificed on day 29th and homogenate of brain (striatal) tissues were taken for biochemical (MDA, GSH and nitrite), neuroinflammatory cytokines ( IL-1β and TNF-α) and neurotransmitters (dopamine, GABA, glutamate) analysis.

Results: Rotenone and manganese administration drastically altered motor co-ordination, induced biochemical, Neuroinflammatory and neurotransmitter changes. Allicin microemulsion (10 and 30 mg/kg; i.p.) significantly alleviated the rotenone and manganese induced motor deficit, biochemical and neurotransmitters alteration in rats through antioxidant, anti-inflammatory and neuroprotective mechanisms.

Conclusion: Present observation of the study revealed that allicin microemulsion could serve as fascinating strategy in preventing neurodegeneration through antioxidant, anti-inflammatory and neuromodulatory potential.

References: Donzanti BA, Yamamoto BK (1988) An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. Life sciences 43,913-922. Liu TH, Luo CL, Huang B, Lu TS and Fu YS (2018) The caffeine effects on rotenone-induced Parkinson’s disease model in vitro and in vivo. The FASEB Journal, 32, pp.740-2.

To cite this abstract in AMA style:

S. Singh. Neuroprotective effects of allicin microemulsion against intrastriatal rotenone and manganese induced Parkinsonism in rats [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/neuroprotective-effects-of-allicin-microemulsion-against-intrastriatal-rotenone-and-manganese-induced-parkinsonism-in-rats/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuroprotective-effects-of-allicin-microemulsion-against-intrastriatal-rotenone-and-manganese-induced-parkinsonism-in-rats/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley